| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1532-5415.1996.TB02428.X |
| P698 | PubMed publication ID | 8576501 |
| P2093 | author name string | Palumbo B | |
| Parnetti L | |||
| Senin U | |||
| Lowenthal DT | |||
| Palumbo R | |||
| Gobbi G | |||
| Chiarini P | |||
| Pelliccioli GP | |||
| Presciutti O | |||
| Tarducci R | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease | Q33588625 | ||
| Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia | Q33629239 | ||
| In vivo proton spectroscopy in presence of eddy currents | Q33914567 | ||
| Alzheimer's disease: cell-specific pathology isolates the hippocampal formation | Q34261572 | ||
| Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer's type: a continuum? | Q39468028 | ||
| Identification of normal and pathological aging in prospectively studied nondemented elderly humans | Q41082915 | ||
| The investigation of Alzheimer's disease with single photon emission tomography | Q41786659 | ||
| SPECT in the diagnosis of Alzheimer's disease and multi-infarct-dementia | Q43916472 | ||
| Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease | Q43958274 | ||
| Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease | Q45289669 | ||
| Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy | Q45291253 | ||
| Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease | Q46662716 | ||
| Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia | Q48305999 | ||
| Spectral analysis of the EEG and 99m-Tc-HMPAO SPECT-scan in Alzheimer's disease | Q48345933 | ||
| The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. | Q51183354 | ||
| Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. | Q52068802 | ||
| The Global Deterioration Scale for assessment of primary degenerative dementia | Q57279034 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 133-138 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Journal of the American Geriatrics Society | Q6296094 |
| P1476 | title | 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease | |
| P478 | volume | 44 |
| Q30772153 | A critical discussion of the role of neuroimaging in mild cognitive impairment |
| Q51953733 | APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss. |
| Q41670491 | Age-associated memory impairment. Normal aging or warning of dementia? |
| Q35236545 | Age-related mild cognitive deficit: a ready-to-use concept? |
| Q24594531 | Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play |
| Q50937697 | Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. |
| Q48315712 | Apolipoproteins E and C1 and brain morphology in memory impaired elders. |
| Q34625093 | Brain ageing in the new millennium |
| Q30585268 | Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly |
| Q60010754 | Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts |
| Q30770505 | Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging |
| Q30975605 | Imaging in psychiatric illnesses |
| Q81554231 | In vivo proton magnetic resonance spectroscopy in patients with neuroacanthocytosis |
| Q71941411 | Insurance underwriting in the genetic era |
| Q37309161 | Low nocturnal blood pressure is associated with reduced cerebral blood flow in the cohort "Men born in 1914" |
| Q42655692 | Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses |
| Q48866034 | MRI and genetic correlates of cognitive function in elders with memory impairment |
| Q48713871 | MRI of human entorhinal cortex: a reliable protocol for volumetric measurement |
| Q32066231 | MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects |
| Q37672946 | MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging. |
| Q30660816 | Magnetic resonance imaging and magnetic resonance spectroscopy in dementias |
| Q48641594 | Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects |
| Q33911331 | Mild cognitive impairment: potential pharmacological treatment options |
| Q41628465 | Modulation of acetylcholine release in human cortical slices: possible implications for Alzheimer's disease |
| Q58856380 | NMR spectroscopy in pharmacy |
| Q52017695 | Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. |
| Q51980686 | Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease. |
| Q44780808 | Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy |
| Q30606675 | Proton MRS in mild cognitive impairment |
| Q36871035 | Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging |
| Q33462288 | Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment |
| Q44169486 | Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease |
| Q46622896 | Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study |
| Q46885074 | Proton spectroscopy in Alzheimer's disease and cognitive impairment not dementia: a community study |
| Q52003246 | Questionable dementia: clinical course and predictors of outcome. |
| Q35749809 | Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients |
| Q37407266 | Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study |
| Q44986754 | Relevance of functional neuroimaging in the progression of mild cognitive impairment |
| Q35749793 | Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD |
| Q52093068 | The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease. |
| Q50864645 | [Memory complaints and the diagnosis of dementia] |
Search more.